Cargando…

Left atrial appendage closure with the II generation Ultraseal device: An international registry. The LIGATE study

OBJECTIVES: To assess feasibility and safety of second‐generation left atrial appendage closure (LAAC) Ultraseal device in patients with nonvalvular atrial fibrillation (NVAF). BACKGROUND: LAAC with first‐generation Ultraseal device (Cardia, Eagan, Minnesota) has been shown to be a feasible therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pivato, Carlo A., Liccardo, Gaetano, Sanz‐Sanchez, Jorge, Pelloni, Elisa, Pujdak, Krzysztof, Xuareb, Robert G., Cruz‐Gonzalez, Ignacio, Pisano, Francesco, Scotti, Andrea, Tarantini, Giuseppe, Cook, Stephane, Regazzoli, Damiano, Reimers, Bernhard, Condorelli, Gianluigi, Bragato, Renato Maria, Stefanini, Giulio G., Pagnotta, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Valvular and Structural Heart Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796275/ https://www.ncbi.nlm.nih.gov/pubmed/35842775 http://dx.doi.org/10.1002/ccd.30336

Ejemplares similares

Long term follow‐up after balloon expandable covered stents implantation for management of transcatheter aortic valve replacement related vascular access complications
por: Maurina, Matteo, et al.
Publicado: (2022)

Facilitation techniques to cross the interatrial septum with intracardiac echocardiography during left atrial appendage closure
por: Vanhaverbeke, Maarten, et al.
Publicado: (2022)

Temporal changes and clinical significance of peridevice leak following left atrial appendage occlusion with Amplatzer devices
por: Korsholm, Kasper, et al.
Publicado: (2022)

TAVR and stroke: A common evolution
por: Tarantini, Giuseppe, et al.
Publicado: (2022)

Uninterrupted vitamin K antagonists in patients undergoing transcatheter aortic valve implantation: A promising strategy still looking for the right patient
por: Tarantini, Giuseppe, et al.
Publicado: (2022)

Novel oral anticoagulants versus vitamin K antagonists in transcatheter aortic valve replacement treated patients—Patients' vulnerability still matters
por: Tarantini, Giuseppe, et al.
Publicado: (2022)

Transcatheter aortic valve replacement for native and prosthetic aortic regurgitation: Two birds with one stone
por: Tarantini, Giuseppe, et al.
Publicado: (2022)

SAPIEN 3 transcatheter heart valve in patients with borderline annulus: “stretched better than bigger?”
por: Tarantini, Giuseppe, et al.
Publicado: (2022)

Association Between Colchicine Treatment and Clinical Outcomes in Patients with Coronary Artery Disease: Systematic Review and Meta-analysis
por: Condello, Francesco, et al.
Publicado: (2021)

Percutaneous closure of “hidden” left atrial appendage with Ultraseal device
por: Moreno-Samos, Jose Carlos, et al.
Publicado: (2019)

Single center TAVR experience with a focus on the prevention and management of catastrophic complications
por: Kapadia, Samir R, et al.
Publicado: (2014)

Supra‐annular structure assessment for self‐expanding transcatheter heart valve size selection in patients with bicuspid aortic valve
por: Liu, Xianbao, et al.
Publicado: (2018)

A comparison of valve‐in‐valve transcatheter aortic valve replacement in failed stentless versus stented surgical bioprosthetic aortic valves
por: Choi, Charles H., et al.
Publicado: (2018)

Clinical outcomes of the Lotus Valve in patients with bicuspid aortic valve stenosis: An analysis from the RESPOND study
por: Blackman, Daniel J., et al.
Publicado: (2019)

Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO‐3 randomized trial
por: Zilberszac, Robert, et al.
Publicado: (2019)

One‐year clinical outcome with a novel self‐expanding transcatheter heart valve
por: Pellegrini, Costanza, et al.
Publicado: (2019)

Comparison of the Sapien 3 versus the ACURATE neo valve system: A propensity score analysis
por: Kooistra, Nynke H., et al.
Publicado: (2020)

Clinical risk model for predicting 1‐year mortality after transcatheter aortic valve replacement
por: Yamamoto, Masanori, et al.
Publicado: (2020)

Tricuspid regurgitation after transcatheter mitral valve repair: Clinical course and impact on outcome
por: Meijerink, Frank, et al.
Publicado: (2021)

Dedicated plug based closure for large bore access –The MARVEL prospective registry
por: Kroon, Herbert G., et al.
Publicado: (2020)

Hemodynamic comparison of transcatheter aortic valve replacement with the SAPIEN 3 Ultra versus SAPIEN 3: The HomoSAPIEN registry
por: Moriyama, Noriaki, et al.
Publicado: (2020)

Comparative differences of mitral valve‐in‐valve implantation: A new mitral bioprosthesis versus current mosaic and epic valves
por: Wang, Dee Dee, et al.
Publicado: (2021)

Doing procedures for patients rather than to patients
por: Malik, Shahbaz A., et al.
Publicado: (2022)

Transcatheter mitral valve repair in a high‐surgical risk patient with severe degenerative mitral regurgitation using the novel DragonFly™ Transcatheter Repair device—First in man implantation in China
por: Liu, Xianbao, et al.
Publicado: (2021)

Volume of contrast to creatinine clearance ratio predicts early mortality and AKI after TAVI
por: Venturi, Gabriele, et al.
Publicado: (2022)

Transcatheter aortic valve implantation with the novel‐generation Navitor device: Procedural and early outcomes
por: Corcione, Nicola, et al.
Publicado: (2022)

Cardiovascular outcomes in patients with left atrial enlargement undergoing transcatheter aortic valve implantation
por: Asami, Masahiko, et al.
Publicado: (2022)

The impact of frailty on adverse outcomes after transcatheter aortic valve replacement in older adults: A retrospective cohort study
por: Dautzenberg, Lauren, et al.
Publicado: (2022)

Percutaneous closure of patent foramen ovale for treatment of hypoxemia: A case series and physiology review
por: Robl, Jared, et al.
Publicado: (2022)

Mass to voltage ratio index predicts mortality following TAVI
por: Porat, Alon, et al.
Publicado: (2022)

Temporal trends in transcatheter aortic valve replacement use and outcomes by race, ethnicity, and sex
por: Yong, Celina M., et al.
Publicado: (2022)

Endocarditis following transcatheter or surgical aortic valve replacement: What's the difference?
por: Goldsweig, Andrew M., et al.
Publicado: (2022)

Final 3‐year clinical outcomes following transcatheter aortic valve implantation with a supra‐annular self‐expanding repositionable valve in a real‐world setting: Results from the multicenter FORWARD study
por: Van Mieghem, Nicolas M., et al.
Publicado: (2021)

Insights in a restricted temporary pacemaker strategy in a lean transcatheter aortic valve implantation program
por: Hokken, Thijmen W., et al.
Publicado: (2021)

Percutaneous decannulation of extracorporeal membrane oxygenation using a plug‐based closure device
por: Dalén, Magnus, et al.
Publicado: (2022)

Percutaneous approach to left ventricular assist device decommissioning
por: Moroni, Francesco, et al.
Publicado: (2022)

A patient‐specific algorithm to achieve commissural alignment with Acurate Neo: The sextant technique
por: De Marco, Federico, et al.
Publicado: (2021)

Vascular complications with a plug‐based vascular closure device after transcatheter aortic valve replacement: Predictors and bail‐outs
por: van Wiechen, Maarten P., et al.
Publicado: (2021)

Cerebral embolic protection and severity of stroke following transcatheter aortic valve replacement
por: Isogai, Toshiaki, et al.
Publicado: (2022)

Procedural and long‐term outcome among patients undergoing expedited trans‐catheter aortic valve replacement
por: Berkovitch, Anat, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h5lgiguudamqj2up69b3hh2bjt